Exacerbation

Rothnie, K. J., Numbere, B., Gelwicks, S., Lu, Y., Sharma, R., Compton, C., et al. (2023). Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. Int J Chron Obstruct Pulmon Dis, 18, 2673-2685. http://doi.org/10.2147/copd.s413947

View

Kallis, C., Calvo, R. A., Schuller, B., & Quint, J. K. (2023). Development of an Asthma Exacerbation Risk Prediction Model for Conversational Use by Adults in England. Pragmat Obs Res, 14, 111-125. http://doi.org/10.2147/por.s424098

View

Ismaila, A. S., Rothnie, K. J., Wood, R. P., Banks, V. L., Camidge, L. J., Czira, A., et al. (2023). Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respir Res, 24, 229. http://doi.org/10.1186/s12931-023-02523-1

View